
The Cooper Companies COO
$ 64.3
-0.19%
Quarterly report 2025-Q4
added 03-06-2026
The Cooper Companies Cash Conversion Cycle 2011-2026 | COO
Annual Cash Conversion Cycle The Cooper Companies
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 210 | 205 | 185 | 185 | 214 | 218 | 205 | 185 | 201 | 197 | 210 | 213 | 203 | 224 | 192 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 224 | 185 | 203 |
Quarterly Cash Conversion Cycle The Cooper Companies
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 239 | - | 224 | 248 | 245 | - | 213 | 225 | 213 | - | 194 | 195 | 182 | 1.06 K | 186 | 185 | 227 | 77.4 | 221 | 217 | 221 | 115 | 234 | 242 | 215 | 107 | 201 | 215 | 211 | 95.8 | 178 | 178 | 210 | 102 | 194 | 212 | 210 | 101 | 195 | 204 | 221 | 109 | 202 | 209 | 228 | 109 | 218 | 225 | 218 | 102 | 197 | 211 | 242 | 111 | 212 | 213 | 213 | 99.3 | 174 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.06 K | 77.4 | 205 |
Cash Conversion Cycle of other stocks in the Medical instruments industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
253 K | - | - | $ 810 M | ||
|
Luminex Corporation
LMNX
|
18.9 | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
95.3 | - | -9.52 % | $ 20.6 M | ||
|
iRhythm Technologies
IRTC
|
59.8 | $ 126.93 | 3.74 % | $ 4.06 B | ||
|
Alcon
ALC
|
134 | $ 76.13 | 0.46 % | $ 40.4 B | ||
|
Ekso Bionics Holdings
EKSO
|
404 | $ 10.93 | -0.55 % | $ 26.5 M | ||
|
Antares Pharma, Inc.
ATRS
|
204 | - | - | $ 955 M | ||
|
Repro Med Systems
KRMD
|
83.1 | $ 4.03 | 1.77 % | $ 186 M | ||
|
Cantel Medical Corp.
CMD
|
400 | - | -1.18 % | $ 3.4 B | ||
|
Hill-Rom Holdings, Inc.
HRC
|
11.9 | - | -0.05 % | $ 10.3 B | ||
|
Microbot Medical
MBOT
|
-52.9 | $ 2.17 | -1.36 % | $ 99.4 M | ||
|
Milestone Scientific
MLSS
|
533 | $ 0.32 | 1.15 % | $ 26.3 M | ||
|
Varian Medical Systems, Inc.
VAR
|
194 | - | -0.02 % | $ 16.3 B | ||
|
Haemonetics Corporation
HAE
|
217 | $ 60.81 | 1.38 % | $ 3.06 B | ||
|
electroCore
ECOR
|
-39.3 | $ 6.07 | -1.7 % | $ 51.5 K | ||
|
ICU Medical
ICUI
|
146 | $ 122.32 | -2.0 % | $ 3.01 B | ||
|
Envista Holdings Corporation
NVST
|
77.3 | $ 26.79 | - | $ 4.5 B | ||
|
Isoray
ISR
|
173 | - | 0.03 % | $ 108 M | ||
|
Intuitive Surgical
ISRG
|
203 | $ 471.29 | -2.27 % | $ 168 B | ||
|
Glaukos Corporation
GKOS
|
170 | $ 121.88 | 0.18 % | $ 5.9 B | ||
|
STERIS plc
STE
|
112 | $ 221.92 | 0.08 % | $ 21.9 B | ||
|
Teleflex Incorporated
TFX
|
285 | $ 136.38 | -0.13 % | $ 6.09 B | ||
|
Masimo Corporation
MASI
|
83.7 | $ 178.6 | -0.02 % | $ 9.52 B | ||
|
InfuSystem Holdings
INFU
|
24.9 | $ 10.6 | 2.71 % | $ 219 M | ||
|
Merit Medical Systems
MMSI
|
167 | $ 67.27 | -1.91 % | $ 3.98 B | ||
|
Utah Medical Products
UTMD
|
321 | $ 67.07 | -0.15 % | $ 217 M | ||
|
West Pharmaceutical Services
WST
|
97.3 | $ 301.01 | -1.6 % | $ 21.8 B | ||
|
Pulse Biosciences
PLSE
|
-1.51 K | $ 22.39 | -2.74 % | $ 1.51 B | ||
|
DENTSPLY SIRONA
XRAY
|
66 | $ 11.9 | -0.13 % | $ 2.37 B | ||
|
Retractable Technologies
RVP
|
203 | $ 0.63 | -1.72 % | $ 18.9 M | ||
|
Pro-Dex
PDEX
|
193 | $ 51.94 | -0.32 % | $ 171 M | ||
|
LeMaitre Vascular
LMAT
|
29 | $ 115.31 | 1.64 % | $ 2.61 B | ||
|
Predictive Oncology
POAI
|
-7.15 K | - | - | $ 31.1 M | ||
|
STAAR Surgical Company
STAA
|
26 | $ 26.2 | 2.06 % | $ 1.3 B | ||
|
BioLife Solutions
BLFS
|
37.9 | $ 21.31 | -0.33 % | $ 982 M | ||
|
Stereotaxis
STXS
|
143 | $ 1.94 | 0.26 % | $ 176 M | ||
|
Baxter International
BAX
|
106 | $ 18.46 | 1.68 % | $ 9.47 B | ||
|
ResMed
RMD
|
167 | $ 222.96 | 1.47 % | $ 32.6 B | ||
|
AtriCure
ATRC
|
185 | $ 29.06 | -0.75 % | $ 1.39 B | ||
|
Harvard Bioscience
HBIO
|
243 | $ 6.56 | -4.37 % | $ 291 M | ||
|
NeuroMetrix
NURO
|
357 | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
124 | $ 11.01 | -0.81 % | $ 450 M | ||
|
Becton, Dickinson and Company
BDX
|
110 | $ 150.72 | -0.92 % | $ 43.4 B | ||
|
Nephros
NEPH
|
161 | $ 2.99 | 4.3 % | $ 31.1 M | ||
|
OraSure Technologies
OSUR
|
211 | $ 2.97 | -1.17 % | $ 218 M | ||
|
Repligen Corporation
RGEN
|
272 | $ 118.39 | 0.67 % | $ 6.6 M |